Posted in | News | Business

Rio Tinto Announce Investmenet to Expand Iron Ore Exploration in Canada

Rio Tinto continues to advance its three-phased strategy that would see the Iron Ore Company of Canada’s annual concentrate production expand by 50 per cent to 26 million tonnes by 2011.


Rio Tinto today approved the $US193 million capital expenditure (Rio Tinto share $US102 million) magnetite plant expansion to an annual capacity of 22.8 million tonnes.

Rio Tinto has also approved US$75 million (Rio Tinto share US$44 million) for completion of a feasibility study on the third-phase expansion, to extend annual capacity to 26 million tonnes and purchase of long-lead items.

Overall, taking into account earlier preparatory work, a total of US$768 million has now been committed to the expansions (Rio Tinto share US$451 million).
“The iron ore market remains tight and our substantial reinvestment in our operations in Canada and worldwide demonstrates the confidence we have in that market,” Rio Tinto chief executive iron ore and IOC chairman Sam Walsh said.

“The significant improvement in IOC operational efficiency is now being reflected in a more aggressive expansion timetable. We are targeting an annual production run-rate of 26 million tonnes of concentrate in late 2011,” he said.

“A number of new market opportunities are emerging for both concentrate and pellet products and it is important that IOC extracts maximum efficiency from its existing infrastructure and plant.”

The phased expansion has significant and sustainable local benefits, particularly in employment opportunities.

The IOC expansion follows on from the July announcement of a US$2.15 billion expansion of the Corumbá iron ore mine in Brazil. Rio Tinto has now spent or committed US$11 billion since the current expansion phase commenced in 2003, towards its goal to reach an annual iron ore capacity of more than 600 million tonnes.
 

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.